Last updated on July 2020

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)


Brief description of study

The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant Ovarian Cancer.

Clinical Study Identifier: NCT03398655

Find a site near you

Start Over

Rabin Medical Center

Petach Tikva, Israel
6.61miles
  Connect »

Chaim Sheba Medical Center

Ramat Gan, Israel
9.0miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.